Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)

Market Cap	3.49B
Revenue (ttm)	403.38M
Net Income (ttm)	30.83M
Shares Out	507.51M
EPS (ttm)	0.06
PE Ratio	113.21
Forward PE	n/a
Dividend	0.05 (0.73%)
Ex-Dividend Date	n/a

Volume	9,386,664
Average Volume	8,534,362
Open	6.89
Previous Close	6.95
Day's Range	6.86 - 7.10
52-Week Range	5.66 - 9.30
Beta	0.75
RSI	51.76
Earnings Date	Apr 12, 2025

About SHE:002198

Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, tonic, and gastrointestinal diseases. It also provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablets (capsules), Shufeng Huoluo tablets, Tiaomeng Huoxue tablets, etc. Guangdong Jiaying Pharmaceutical Co., Ltd. was founded in 2003 and is based in Meiz...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2003
• Employees: 700
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002198

Financial Performance

In 2024, SHE:002198's revenue was 376.17 million, a decrease of -29.46% compared to the previous year's 533.23 million. Earnings were 20.61 million, a decrease of -39.94%.